| #31 |
Boris Rozenfeld |
Pitney Bowes |
1 |
| #31 |
Alex Frenkel |
Elta Systems |
1 |
| #31 |
Sergio Lopes Fernandes da Costa |
— |
1 |
| #31 |
Joseph Biraglia |
— |
1 |
| #31 |
Nico Hawk LaRosa |
— |
1 |
| #31 |
Nizar Haddad |
BOE |
1 |
| #31 |
Daniel Robert Fandrick |
BOE |
1 |
| #31 |
James P. Cipriani |
IBM |
1 |
| #31 |
Naouel Baili Ben Abdallah |
Iqvia |
1 |
| #31 |
Joshua Kessler |
Mastercard |
1 |
| #31 |
Steven Medd |
Entegris |
1 |
| #31 |
Mark O'Donnell |
Macton |
1 |
| #31 |
Oleg Petrenko |
RTX (Raytheon) |
1 |
| #31 |
James B. Walzak |
Fuelcell Energy |
1 |
| #31 |
Edgar La Borde |
Entegris |
1 |
| #31 |
Adrish Ganguly |
Greatbatch |
1 |
| #31 |
Michael G. Crisanti |
Henkel Ip & Holding Gmbh |
1 |
| #31 |
Zack Z. Qu |
Newfrey |
1 |
| #31 |
Daniel Anthony DeMarco |
IBM |
1 |
| #31 |
Jim Woyciesjes |
Newfrey |
1 |
| #31 |
Allen J. Bancroft |
White Consolidated Industries |
1 |
| #31 |
John Strein |
Regeneron Pharmaceuticals |
1 |
| #31 |
Alexander K. Raub |
Stc.Unm |
1 |
| #31 |
Ta-Hsin Li |
IBM |
1 |
| #31 |
Todd W. Mummert |
IBM |
1 |
| #31 |
James Botelho |
Perkinelmer Health Sciences |
1 |
| #31 |
Joseph Neuhaus Dowdell |
Hubbell Incorporated |
1 |
| #31 |
Roger John Snow |
BOE |
1 |
| #31 |
Joseph P. Tomanic |
Schlumberger Technology |
1 |
| #31 |
Xiaowen HOU |
Isp Investments |
1 |
| #31 |
John DiCarlo |
Qiagen Sciences |
1 |
| #31 |
Peter M. Woyciesjes |
Prestone Products |
1 |
| #31 |
Dave Musgrove |
Iqvia |
1 |
| #31 |
Ivan Gudzei |
Iqvia |
1 |
| #31 |
Vladimir Karaychentsev |
Iqvia |
1 |
| #31 |
Sharad N. Yedave |
Entegris |
1 |
| #31 |
Cheng-Kon Shih |
Aerie Pharmaceuticals |
1 |
| #31 |
Jerome J. Workman, Jr. |
Westco Scientific Instruments |
1 |
| #31 |
James A. Johnson |
ExxonMobil |
1 |
| #31 |
Farid Agahi |
IBM |
1 |
| #31 |
Erick Richard Roush Young |
BOE |
1 |
| #31 |
Laura A. Dellevigne |
PepsiCo |
1 |
| #31 |
Martin Wusik |
Momentive Performance Materials Gmbh |
1 |
| #31 |
Mikel EZCURRA |
Newfrey |
1 |